Over the past 20 years, Novartis has continued to address chronic myeloid leukemia (CML) innovation with a relentless commitment to patients with CML who continue to face unmet needs.
Learn more: [ Ссылка ]
©2021 Novartis AG
Ещё видео!
Over the past 20 years, Novartis has continued to address chronic myeloid leukemia (CML) innovation with a relentless commitment to patients with CML who continue to face unmet needs.
Learn more: [ Ссылка ]
©2021 Novartis AG